Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genome-wide scale. However, in many cases, no obvious correlation between expression of well-known tumour-related genes (that is, p53, p73 and p21) and survival rates of patients has been observed. This can be mainly explained by the complex molecular mechanisms involved in cancer, which mask the clinical relevance of a gene with multiple functions if only gene expression status is considered. As we demonstrate here, in many such cases, the expression of the gene interaction partners (gene 'interactome') correlates significantly with cancer survival and is indicative of the role of that gene in cancer. On the basis of this principle, we have imple...
Abstract A fundamental goal in cancer-associated genome sequencing is to identify the key genes. Pro...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Abstract Breast cancer is the most common cancer and the leading cause of cancer-related deaths in w...
Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genom...
Early cancer diagnosis and prognosis prediction are necessary for cancer patients. Effective identif...
Abstract To screen the key genes in the development of gastric cancer and their influence on prognos...
Protein-protein interactions (PPIs) have been widely studied to understand the biological processes ...
The simultaneous measurement of thousands of genes gives the opportunity to personalize and improve ...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Background: Clinical statement alone is not enough to predict the progression of disease. Instead, t...
Background: Systematic approaches for identifying proteins involved in different types of cancer are...
Over the past decade, conventional lab work strategies have gradually shifted from being limited to ...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Abstract Background Censored data are increasingly common in many microarray studies that attempt to...
The main hallmarks of cancer diseases are the evasion of programmed cell death, uncontrolled cell di...
Abstract A fundamental goal in cancer-associated genome sequencing is to identify the key genes. Pro...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Abstract Breast cancer is the most common cancer and the leading cause of cancer-related deaths in w...
Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genom...
Early cancer diagnosis and prognosis prediction are necessary for cancer patients. Effective identif...
Abstract To screen the key genes in the development of gastric cancer and their influence on prognos...
Protein-protein interactions (PPIs) have been widely studied to understand the biological processes ...
The simultaneous measurement of thousands of genes gives the opportunity to personalize and improve ...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Background: Clinical statement alone is not enough to predict the progression of disease. Instead, t...
Background: Systematic approaches for identifying proteins involved in different types of cancer are...
Over the past decade, conventional lab work strategies have gradually shifted from being limited to ...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Abstract Background Censored data are increasingly common in many microarray studies that attempt to...
The main hallmarks of cancer diseases are the evasion of programmed cell death, uncontrolled cell di...
Abstract A fundamental goal in cancer-associated genome sequencing is to identify the key genes. Pro...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Abstract Breast cancer is the most common cancer and the leading cause of cancer-related deaths in w...